Introducing a high-risk HPV DNA test into a public sector screening program in El Salvador

Journal of Lower Genital Tract Disease

Volumn 20, Issue 2, 2016, Pages 145-150

  Cremer, Miriam L ^a,b   Maza, Mauricio ^a   Alfaro, Karla M ^a   Kim, Jane J ^c   Ditzian, Lauren R ^a   Villalta, Sofia ^d   Alonzo, Todd A ^e   Felix, Juan C ^e   Castle, Philip E ^f   Gage, Julia C ^g  

^a Basic Health International San Salvador   (El Salvador)

^b LERNER RESEARCH INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Ministry of Health of El Salvador   (El Salvador)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Care HPV; Cervical cancer; Human papillomavirus; Latin America; Screening program

Indexed keywords

ACETIC ACID;

ADULT; ARTICLE; COHORT ANALYSIS; COLPOSCOPY; CRYOTHERAPY; DEMOGRAPHY; EDUCATIONAL STATUS; EL SALVADOR; ELECTROSURGERY; FEMALE; FOLLOW UP; HEALTH PROMOTION; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HYSTERECTOMY; LOOP ELECTROSURGICAL EXCISION PROCEDURE; MAJOR CLINICAL STUDY; ORGANIZATION AND MANAGEMENT; PAPILLOMAVIRUS INFECTION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT REFERRAL; PRACTICE GUIDELINE; PROGRAM EVALUATION; SCREENING TEST; SEXUALITY; URBAN AREA; UTERINE CERVIX CARCINOMA IN SITU; COMPLICATION; EARLY CANCER DIAGNOSIS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; PUBLIC SECTOR; UTERINE CERVICAL NEOPLASMS; UTILIZATION; VIROLOGY;

ADULT; COHORT STUDIES; COLPOSCOPY; CRYOTHERAPY; EARLY DETECTION OF CANCER; EL SALVADOR; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PUBLIC SECTOR; UTERINE CERVICAL NEOPLASMS;

EID: 84958818153     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0000000000000188     Document Type: Article

References (16)

1. YL Qiao, Sellors JW, Eder PS, A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9: 929-36.
2. Zhao FH, Jeronimo J, Qiao YL, An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res (Phila) 2013; 6: 938-48.
3. Goldie SJ, Kuhn L, Denny L, Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA 2001; 285: 3107-15.
4. Rosenbaum AJ, Gage JC, Alfaro KM, Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obstet 2014; 126: 156-60.
5. Campos NG, Maza M, Alfaro K, The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. Int J Cancer 2015; 137: 893-902.
6. WHO Guidelines: Use of Cryotherapy for Cervical Intraepithelial Neoplasia. Geneva: World Health Organization; 2011. Available at: http://www.ncbi.nlm.nih.gov/books/NBK138476. Accessed December 1, 2015.
7. Jacob M, Broekhuizen FF, Castro W, Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings. Int J Gynecol Obstet 2015; 89: S13-20.
8. Chirenje ZM, Rusakaniko S, Akino V, A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia. J Obstet Gynecol 2001; 21: 617-21.
9. McClung EC, Blumenthal PD,. Efficacy, safety, acceptability and affordability of cryotherapy: a review of current literature. Minerva Ginecol 2012; 64: 149-71.
10. Follen Mitchell M, Tortolero-Luna G, Cook E, A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998; 92: 737-44.
11. WHO. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva: World Health Organization; 2013.
12. Everett T, Bryant A, Griffin MF, Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 2011: CD002834.
13. Spadea T, Bellini S, Kunst A, The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review. Prev Med 2010; 50: 159-64.
14. White K, Garces IC, Bandura L, Design and evaluation of a theory-based, culturally relevant outreach model for breast and cervical cancer screening for Latina immigrants. Ethn Dis 2012; 22: 274-80.
15. Pirzadeh A, Mazaheri MA,. The effect of education on women's practice based on the health belief model about Pap smear test. Int J Prev Med 2012; 3: 585-90.
16. Agurto I, Arrossi S, White S, Involving the community in cervical cancer prevention programs. Int J Gynaecol Obstet 2005; 89 (suppl 2): S38-45.